Bio-Key International EBIT

Bio-Key International (BKYI) currently reports a EBIT of $-3.8M as of March 2026. That compares with $-4.2M in the prior-year period — up 9.9% year over year. That is below the Technology sector average of $8.3T. Use the charts on this page to explore Bio-Key International's EBIT history and peer comparisons.

Bio-Key International's EBIT increased from $-4.2M to $-3.8M — a 9.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Key International's EBIT of $-3.8M is lower than the Technology sector average of $8.3T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Bio-Key International reported $-3.8M in EBIT as of March 2026. That compares with $-4.2M in the prior-year period — up 9.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-3.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $8.3T. From there, open related valuation or income-statement pages for Bio-Key International, and consider following BKYI for alerts when major investors trade the stock.